SOUTH SAN FRANCISCO, Calif., March 27, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has entered into a settlement agreement with Annora Pharma Private ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported fourth-quarter earnings of $14.3 million. On a per-share basis ...

Rigel Pharmaceuticals (RIGL) announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA resolving patent litigation related to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SOUTH SAN FRANCISCO – Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), a pharmaceutical company with impressive revenue growth of 54.71% over the last twelve months, has reached a settlement with ...

(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) released earnings for its fourth quarter that increased from the same period last year The company's bottom line came in at $14.34 million, or $0.80 ...